167 related articles for article (PubMed ID: 9097847)
1. [Calcitonin and bone aging].
Reginster JY
Pathol Biol (Paris); 1997 Jan; 45(1):52-6. PubMed ID: 9097847
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin for prevention and treatment of osteoporosis.
Reginster JY
Am J Med; 1993 Nov; 95(5A):44S-47S. PubMed ID: 8256795
[TBL] [Abstract][Full Text] [Related]
3. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
Siminoski K; Josse RG
CMAJ; 1996 Oct; 155(7):962-5. PubMed ID: 8837547
[TBL] [Abstract][Full Text] [Related]
4. Calcitonins and osteoporosis.
Gennari C; Agnusdei D
Br J Clin Pract; 1994; 48(4):196-200. PubMed ID: 7917799
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with calcitonin in osteoporosis.
Gennari C; Agnusdei D; Camporeale A
Horm Metab Res; 1993 Sep; 25(9):484-5. PubMed ID: 8225202
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
Kapetanakis EI; Antonopoulos AS; Antoniou TA; Theodoraki KA; Zarkalis DA; Sfirakis PD; Chilidou DA; Alivizatos PA
J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
8. Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis.
Woo T; Adachi JD
Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):469-81. PubMed ID: 11485341
[TBL] [Abstract][Full Text] [Related]
9. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
Body JJ
Bone; 2002 May; 30(5 Suppl):75S-79S. PubMed ID: 12008163
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the preventive role of estro-progestogens and non-hormonal therapies in postmenopausal osteoporosis].
Reginster JY
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):677-83. PubMed ID: 8991900
[TBL] [Abstract][Full Text] [Related]
12. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
[TBL] [Abstract][Full Text] [Related]
13. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
[TBL] [Abstract][Full Text] [Related]
15. Increase of axial and appendicular trabecular and cortical bone density in established osteoporosis with intermittent nasal salmon calcitonin therapy.
Peichl P; Rintelen B; Kumpan W; Bröll H
Gynecol Endocrinol; 1999 Feb; 13(1):7-14. PubMed ID: 10368793
[TBL] [Abstract][Full Text] [Related]
16. [Calcitonin in the prevention and therapy of osteoporosis].
Ringe JD
Ther Umsch; 1991 Feb; 48(2):91-9. PubMed ID: 2035172
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin therapy in osteoporosis.
Muñoz-Torres M; Alonso G; Raya MP
Treat Endocrinol; 2004; 3(2):117-32. PubMed ID: 15743107
[TBL] [Abstract][Full Text] [Related]
18. Management of osteoporosis due to ovarian failure.
Eastell R
Med Pediatr Oncol; 2003 Sep; 41(3):222-7. PubMed ID: 12868123
[TBL] [Abstract][Full Text] [Related]
19. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
Seeman E
Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
[TBL] [Abstract][Full Text] [Related]
20. [Current treatment concepts in primary osteoporosis: calcitonin].
Ringe JD
Schweiz Med Wochenschr; 1993 Nov; 123(47):2235-40. PubMed ID: 8272794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
